Hrt Financial LP Voyager Therapeutics, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$6.0 - $10.78 $545,310 - $979,740	90,885 New	90,885 $700,000
Q2 2022 Aug 12, 2022	SELL	$4.82 - $10.09 $61,609 - $128,970	-12,782 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.75 - $9.44 $35,150 - $120,662	12,782 New	12,782 $97,000
Q4 2021 Feb 14, 2022	SELL	$2.47 - $5.55 $128,533 - $288,810	-52,038 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.63 - $4.12 $52,828 - $82,758	-20,087 Reduced 27.85%	52,038 $136,000
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $284,172 - $392,360	72,125 New	72,125 $297,000
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $97,999 - $192,172	-21,258 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $151,994 - $261,048	21,258 New	21,258 $151,000

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $216M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.